Literature DB >> 29212028

Non-Canonical Hedgehog Signaling Is a Positive Regulator of the WNT Pathway and Is Required for the Survival of Colon Cancer Stem Cells.

Joseph L Regan1, Dirk Schumacher2, Stephanie Staudte3, Andreas Steffen4, Johannes Haybaeck5, Ulrich Keilholz6, Caroline Schweiger7, Nicole Golob-Schwarzl7, Dominik Mumberg4, David Henderson4, Hans Lehrach8, Christian R A Regenbrecht9, Reinhold Schäfer10, Martin Lange11.   

Abstract

Colon cancer is a heterogeneous tumor driven by a subpopulation of cancer stem cells (CSCs). To study CSCs in colon cancer, we used limiting dilution spheroid and serial xenotransplantation assays to functionally define the frequency of CSCs in a panel of patient-derived cancer organoids. These studies demonstrated cancer organoids to be enriched for CSCs, which varied in frequency between tumors. Whole-transcriptome analysis identified WNT and Hedgehog signaling components to be enhanced in CSC-enriched tumors and in aldehyde dehydrogenase (ALDH)-positive CSCs. Canonical GLI-dependent Hedgehog signaling is a negative regulator of WNT signaling in normal intestine and intestinal tumors. Here, we show that Hedgehog signaling in colon CSCs is autocrine SHH-dependent, non-canonical PTCH1 dependent, and GLI independent. In addition, using small-molecule inhibitors and RNAi against SHH-palmitoylating Hedgehog acyltransferase (HHAT), we demonstrate that non-canonical Hedgehog signaling is a positive regulator of WNT signaling and required for colon CSC survival.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HHAT; PTCH1; SHH; WNT pathway; cancer organoid; cancer stem cell; colon cancer; non-canonical Hedgehog signaling

Mesh:

Substances:

Year:  2017        PMID: 29212028     DOI: 10.1016/j.celrep.2017.11.025

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  44 in total

Review 1.  Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.

Authors:  Ugo Testa; Elvira Pelosi; Germana Castelli
Journal:  Med Sci (Basel)       Date:  2018-04-13

2.  Sonic hedgehog signaling is associated with resistance to zoledronic acid in CD133high/CD44high prostate cancer stem cells.

Authors:  Eda Acikgoz; Gunel Mukhtarova; Araz Alpay; Cigir Biray Avci; Bakiye Goker Bagca; Gulperi Oktem
Journal:  Mol Biol Rep       Date:  2021-05-04       Impact factor: 2.316

Review 3.  Constructing and Deconstructing Cancers using Human Pluripotent Stem Cells and Organoids.

Authors:  Ryan C Smith; Viviane Tabar
Journal:  Cell Stem Cell       Date:  2018-12-20       Impact factor: 24.633

Review 4.  Targeting cancer stem cell pathways for cancer therapy.

Authors:  Liqun Yang; Pengfei Shi; Gaichao Zhao; Jie Xu; Wen Peng; Jiayi Zhang; Guanghui Zhang; Xiaowen Wang; Zhen Dong; Fei Chen; Hongjuan Cui
Journal:  Signal Transduct Target Ther       Date:  2020-02-07

5.  Smoothened-dependent and -independent pathways in mammalian noncanonical Hedgehog signaling.

Authors:  Alessandra V de S Faria; Adamu Ishaku Akyala; Kaushal Parikh; Lois W Brüggemann; C Arnold Spek; Wanlu Cao; Marco J Bruno; Maarten F Bijlsma; Gwenny M Fuhler; Maikel P Peppelenbosch
Journal:  J Biol Chem       Date:  2019-04-16       Impact factor: 5.157

6.  The use of hedgehog antagonists in cancer therapy: a comparison of clinical outcomes and gene expression analyses.

Authors:  Burthia E Booker; Adam D Steg; Stefan Kovac; Charles N Landen; Hope M Amm
Journal:  Cancer Biol Ther       Date:  2020-09-11       Impact factor: 4.742

7.  Cell fate in colon cancer stem cells: To GLI or not to GLI?

Authors:  Joseph L Regan
Journal:  Mol Cell Oncol       Date:  2018-04-19

8.  ETV4 promotes breast cancer cell stemness by activating glycolysis and CXCR4-mediated sonic Hedgehog signaling.

Authors:  Tao Zhu; Juyan Zheng; Wei Zhuo; Pinhua Pan; Min Li; Wei Zhang; Honghao Zhou; Yang Gao; Xi Li; Zhaoqian Liu
Journal:  Cell Death Discov       Date:  2021-05-29

9.  RNA sequencing of long-term label-retaining colon cancer stem cells identifies novel regulators of quiescence.

Authors:  Joseph L Regan; Dirk Schumacher; Stephanie Staudte; Andreas Steffen; Ralf Lesche; Joern Toedling; Thibaud Jourdan; Johannes Haybaeck; Dominik Mumberg; David Henderson; Balázs Győrffy; Christian R A Regenbrecht; Ulrich Keilholz; Reinhold Schäfer; Martin Lange
Journal:  iScience       Date:  2021-05-24

Review 10.  Organoids and Colorectal Cancer.

Authors:  Antonio Barbáchano; Asunción Fernández-Barral; Pilar Bustamante-Madrid; Isabel Prieto; Nuria Rodríguez-Salas; María Jesús Larriba; Alberto Muñoz
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.